Table I.
2 Gy | 10 Gy | 5×2 Gy | ||||
---|---|---|---|---|---|---|
Category | No. of genes | P-value | No. of genes | P-value | No. of genes | P-value |
Pathways in cancer | 11 | 0.0005 | 38 | 1.76×10−16 | 53 | 3.50×10−27 |
Cell cycle | 5 | 0.0069 | 25 | 2.88×10−16 | 28 | 3.48×10−18 |
p53 signaling pathway | 10 | 2.37×10−09 | 15 | 2.07×10−10 | 24 | 2.46×10−20 |
MAPK signaling pathway | 0 | NS | 20 | 2.73×10−06 | 29 | 8.91×10−11 |
Cytokine-cytokine receptor interaction | 7 | 0.0066 | 19 | 2.84×10−06 | 26 | 1.35×10−09 |
DNA replication | 0 | NS | 8 | 2.09×10−06 | 10 | 3.89×10−08 |
TGF-β signaling pathway | 3 | NS | 14 | 1.92×10−08 | 14 | 6.72×10−08 |
Apoptosis | 6 | 0.0007 | 16 | 3.41×10−10 | 17 | 1.40×10−10 |
VEGF signaling pathway | 0 | NS | 9 | 7.35×10−05 | 12 | 8.71×10−07 |
Hepatitis C | 0 | NS | 16 | 1.63×10−07 | 19 | 4.13×10−09 |
Mismatch repair | 0 | NS | 7 | 1.10×10−06 | 8 | 1.20×10−07 |
Nucleotide excision repair | 0 | NS | 7 | 7.45×10−05 | 12 | 1.72×10−09 |
Wnt signaling pathway | 0 | NS | 9 | 0.0076 | 15 | 1.24×10−05 |
Chemokine signaling pathway | 0 | NS | 15 | 2.07×10−05 | 16 | 2.50×10−05 |
B cell receptor signaling pathway | 5 | 0.0022 | 11 | 1.96×10−06 | 10 | 3.51×10−05 |
Base excision repair | 2 | NS | 8 | 3.42×10−06 | 7 | 7.77×10−05 |
Jak-STAT signaling pathway | 6 | 0.0035 | 14 | 1.13×10−05 | 14 | 4.64×10−05 |
Insulin signaling pathway | 4 | NS | 17 | 2.63×10−08 | 17 | 1.20×10−07 |
RIG-I-like receptor signaling pathway | 0 | NS | 2 | NS | 6 | 0.01 |
Toll-like receptor signaling pathway | 0 | NS | 7 | 0.008 | 9 | 0.0013 |
Homologous recombination | 0 | NS | 5 | 0.0006 | 5 | 0.0009 |
No significance; MAPK, mitogen activated protein kinase; TGF, transforming growth factor; VEGF, vascular endothelial growth factor; Wnt, wingless-type MMTV integration site family; Jak, Janus kinase; STAT, signal transducer and activator of transcription.